Founded in California in 2002, Codexis was established specifically to provide unique enzyme optimization services and biocatalyst products for use in industrial processes across the pharmaceutical sector and related markets.
Over the past seven years, we have received three Presidential Green Chemistry Challenge Awards from the US Environmental Protection Agency for our pioneering use of directed evolution for the highly efficient manufacture of blockbuster drugs.
In addition, Codexis’ scientists have published several peer-reviewed scientific papers and filed hundreds of patent applications.
Today, through continued investment in core technology platforms for directed evolution, Codexis is a world leader in biocatalysis.
Over the last decade, innovation and continuous improvement have remained at the heart of Codexis company culture – and will continue to do so.